Advertisement

Document › Details
Agilent Technologies Inc.. (9/20/24). "Press Release: Agilent Completes Acquisition of Biovectra". Santa Clara, CA.
Pharmaceutical customers will benefit from a broader set of specialized CDMO capabilities
Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO) that specializes in biologics, highly potent active pharmaceutical ingredients, and other molecules for targeted therapeutics.
All closing conditions are completed, including receipt of regulatory approvals. BIOVECTRA is now part of Agilent’s Diagnostics and Genomics Group.
“We are delighted to officially welcome the BIOVECTRA team to Agilent,” said Agilent President and CEO Padraig McDonnell. “This acquisition demonstrates our commitment to providing customers the most advanced capabilities to accelerate their therapeutics programs, including best-in-class cGMP pharmaceutical manufacturing.”
With the addition of BIOVECTRA, Agilent will expand its portfolio of CDMO services, add rapidly growing modalities, and bring world-class capabilities to support gene editing. Additional details are available in the news release announcing the acquisition agreement.
Agilent expects the transaction will be $0.05 dilutive to non-GAAP earnings per share (EPS) in the first full year after closing and deliver a double-digit return on invested capital (ROIC) by year five. Agilent funded the transaction using a mix of cash on hand and debt financing.
Additional Information:
FAQs for customers
Highlights for Investors
About Agilent’s Oligonucleotide GMP Manufacturing
About BIOVECTRA
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom.
Follow Agilent on LinkedIn and Facebook.
Investor Contact
Parmeet Ahuja
+1 408-345-8948
parmeet_ahuja@agilent.com
Media Contact
Sarah Litton
+1 408-361-0405
sarah.litton@agilent.com
Record changed: 2025-01-14 |
Advertisement

More documents for Agilent (Group)
- [1] Agilent Technologies Inc.. (12/19/24). "Press Release: Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference". Santa Clara, CA....
- [2] Agilent Technologies Inc.. (12/10/24). "Press Release: Agilent Companion Diagnostic Assay PD-L1 IHC 28-8 pharmDx Receives European IVDR Certification". Santa Clara, CA....
- [3] Agilent Technologies Inc.. (11/25/24). "Press Release: Agilent Announces New Organizational Structure to Support its Market-Focused Strategy". Santa Clara, CA....
- [4] Agilent Technologies Inc.. (11/25/24). "Press Release: Agilent Reports Fourth-Quarter Fiscal Year 2024 Financial Results". Santa Clara, CA....
- [5] Agilent Technologies Inc.. (11/20/24). "Press Release: Agilent 2024 Early Career Professor Award Presented to Adeyemi Adeleye". Santa Clara, CA....
- [6] Tagomics Ltd.. (11/20/24). "Press Release: Tagomics Announces a Multiomic Profiling Co-Marketing Agreement with Agilent". Cambridge....
- [7] Agilent Technologies Inc.. (7/29/24). "Press Release: Agilent Acquires Sigsense, Creator of AI-enabled Lab Operations Technology". Santa Clara, CA....
- [8] Agilent Technologies Inc.. (7/22/24). "Press Release: Agilent to Acquire North American CDMO Biovectra". Santa Clara, CA....
- [9] Agilent Technologies Inc.. (6/25/24). "Press Release: Agilent Names Bret DiMarco Chief Legal Officer"....
- [10] Agilent Technologies Inc.. (5/1/24). "Press Release: Padraig McDonnell Assumes Agilent CEO Role". Santa Clara, CA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top